Assistant Professor of Otolaryngology, Drexel University College of Medicine
Otolaryngology (ENT)
Dr. James E. Blaugrund, MD
James E. Blaugrund, MD practices Otolaryngology (ENT). He graduated from Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He over the years received 5 awards: "Pittsburgh Magazine", "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAO-HNS)", "Top MD" and "Fellow (FACS)". James Blaugrund is a published doctor as well. He has 7 publications published. The latest was: Imaging quiz case 1. Tegmental encephalocele. He accepts Medicare.
Publications
Schools
Yale University School Of Medicine
Johns Hopkins Hospital
Johns Hopkins University School Med
Procedures Preformed
- Antrostomy and Antrotomy (Sinus Surgery)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ethmoidectomy (Sinus Surgery)
- Excision of Parotid, Sublingual, or Submandibular Gland
- View All
Conditions Treated
- Acoustic Neuroma
- Acute Laryngitis
- Acute Sinusitis
- Allergic Rhinitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- Pittsburgh Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO-HNS)
- Top MD
- Fellow (FACS)
Education
-
Johns Hopkins University
-
Yale University School of Medicine
Hospital
-
UPMC Passavant
-
UPMC Presbyterian Shadyside
Drug Facts
NPI NUMBER |
|
1831162312 |
NPPES Provider LastName |
|
BLAUGRUND |
NPPES Provider FirstName |
|
JAMES |
NPPES Provider ZIPCode |
|
152375818 |
NPPES Provider State |
|
PA |
Specialty Description |
|
Otolaryngology |
Total Claim Count |
|
638.0 |
Distinct Opioid Count |
|
1.0 |
Opioid Claim Count |
|
19.0 |
Percent Opioid Claims |
|
2.98 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1831162312 |
Last Name Of The Provider |
BLAUGRUND |
First Name Of The Provider |
JAMES |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog